Clinical Trial Update: A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines [Phase 4]

View source ↗

Summary

Phase 4 trial assessing two doses of Shanchol Oral Cholera Vaccine in individuals aged 1 year and older in the Philippines has completed. The sponsor is Sanofi …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• Shanchol (oral cholera vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Cholera | Phase 4 | Status: COMPLETED